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Supplementary Figure S1. Flow cytometry histograms of pCS321-based constructs bearing control and library Rnt1p hairpins. The 
shaded population (grey) indicates the noninduced cell population and was generated from cells harboring the ‘no insert’ control in the 
absence of galactose. Histograms are representative of three independent experiments. (A) Histograms of constructs bearing the A01 
and A02 control hairpins. (B) Histograms of constructs bearing the C05, C07, and C08 library hairpins. 
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Supplementary Figure S2. Sequences and structures of the final Rnt1p cleavage library and the positive control Rnt1p hairpins. 
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Supplementary Figure S3. Flow cytometry histograms of pCS1749-based constructs bearing control and library Rnt1p hairpins. The 
empty vector histogram (grey) lacks a fluorescent gene and is indicative of the cell and media autofluorescence. Histograms are 
representative of three independent experiments. 
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Supplementary Figure S4. Correlation analysis of protein and transcript levels for all hairpins identified from the fluorescence-based 
in vivo screening assay. Color scheme is as follows: final library hairpins selected for structural stability to act as modular control 
elements, blue; library hairpins not selected for inclusion in the final Rnt1p hairpin library, black. The regression line is determined 
from the entire data set and indicates an r-value of 0.629. The r-value for an identical analysis performed on the data set in blue 
indicates a stronger correlation (r value = 0.817, Figure 3C). All normalized protein and transcript levels are determined as described 
in Figure 1D. 
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Supplementary Figure S5. Plasmid maps for key constructs used in this work. (A) Plasmid map of pCS321, the yGFP3 
characterization plasmid. (B) Plasmid map of pCS1749, the ymCherry characterization plasmid. (C) Plasmid map of pCS1813, the 
Rnt1p hairpin integration plasmid. 
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Supplementary Table SI. Sequence and in vivo characterization data for all screened Rnt1p hairpins. The nucleotides of the cleavage 
efficiency box are indicated in red. Constructs labeled with ‘C’ or ‘A’ represent the final selected cleavage library and positive 
controls. Constructs labeled with ‘c’ represent screened hairpins not selected for inclusion in the final Rnt1p hairpin library. All 
normalized protein and transcript levels are determined as described in Figure 1D. 
 
Substrate Sequence Normalized protein levels (%) Normalized transcript levels (%) 
C01 GGCGUCGACUUGUCAUGUCAUGAGUCCAUGGCAUGGCAAGGAAACGCC 84% ± 6% 68% ± 3% 
C02 GGCGGGUAUAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUUGCUCCGCC 80% ± 3% 71% ± 7% 
C03 GGCGUGCUUUUGUCAUGUCAUGAGUCCAUGGCAUGGCAAAUUAUCGCC 55% ± 1% 60% ± 9% 
C04 GGCGCCAGAGUGUCAUGUCAUGAGUCCAUGGCAUGGCAAUUUUGCGCC 20% ± 1% 31% ± 4% 
C05 GGCGAACCAAUGUCAUGUCAUGAGUCCAUGGCAUGGCACUAAUUCGCC 55% ± 2% 51% ± 5% 
C06 GGCGCUCACAUGUCAUGUCAUGAGUCCAUGGCAUGGCAGCGAGCCGCC 33% ± 2% 55% ± 5% 
C07 GGCGGUUGUAUGUCAUGUCAUGAGUCCAUGGCAUGGCAAAAAACCGCC 41% ± 1% 67% ± 13% 
C08 GGCGUUUAGAUGUCAUGUCAUGAGUCCAUGGCAUGGCAGUUAGACGCC 11% ± 0% 12% ± 2% 
C09 GGCGUGUCUGUGUCAUGUCAUGAGUCCAUGGCAUGGCAUACACACGCC 25% ± 1% 28% ± 4% 
C10 GGCGGGGUAUUGUCAUGUCAUGAGUCCAUGGCAUGGCACUAAGACGCC 46% ± 1% 66% ± 8% 
C11 GGCGUAACAAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUCGUAACGCC 11% ± 0% 56% ± 10% 
C12 GGCGAUAACUUGUCAUGUCAUGAGUCCAUGGCAUGGCACCUAGUCGCC 81% ± 6% 75% ± 12% 
C13 GGCGCUAUCGUGUCAUGUCAUGAGUCCAUGGCAUGGCAUGAUAGCGCC 8% ± 0% 12% ± 1% 
C14 GGCGGACAGAUGUCAUGUCAUGAGUCCAUGGCAUGGCACGUAUUCGCC 85% ± 3% 83% ± 6% 
A01 GGCGAUGUCAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUGGCAUCGCC 59% ± 2% 53% ± 5% 
A02 GGCGCAUUCAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUGGAUGCGCC 28% ± 1% 43% ± 8% 
c01 GGCGACUUACUGUCAUGUCAUGAGUCCAUGGCAUGGCAUAUGCCCGCC 102% ± 2% 80% ± 13% 
c02 GGCGAUUCGCUGUCAUGUCAUGAGUCCAUGGCAUGGCAAAACGCCGCC 95% ± 6% 58% ± 8% 
c03 GGCGAACUUAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUAAUAACGCC 31% ± 1% 64% ± 13% 
c04 GGCGGGACAGUGUCAUGUCAUGAGUCCAUGGCAUGGCAUAGUUGCGCC 22% ± 1% 27% ± 3% 
c05 GGCGUUAUGAUGUCAUGUCAUGAGUCCAUGGCAUGGCAAUGUUGCGCC 36% ± 1% 40% ± 4% 
c06 GGCGGUCGCAUGUCAUGUCAUGAGUCCAUGGCAUGGCAGUCUAACGCC 37% ± 2% 29% ± 3% 
c07 GGCGUUUGGCUGUCAUGUCAUGAGUCCAUGGCAUGGCAAUCAUGCGCC 16% ± 0% 32% ± 4% 
c08 GGCGAUGAAAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUUUACGCGCC 38% ± 2% 54% ± 5% 
c09 GGCGGUAAAGUGUCAUGUCAUGAGUCCAUGGCAUGGCAUUAUAGCGCC 46% ± 1% 50% ± 6% 
c10 GGCGUUUUAGUGUCAUGUCAUGAGUCCAUGGCAUGGCAAAAAUGCGCC 75% ± 3% 73% ± 10% 
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Supplementary Table SI cont’d. 
 
Substrate Sequence Normalized protein levels (%) Normalized transcript levels (%) 
c11 GGCGGGUAGUUGUCAUGUCAUGAGUCCAUGGCAUGGCAAGUGGACGCC 24% ± 1% 15% ± 3% 
c12 GGCGAUUCAGUGUCAUGUCAUGAGUCCAUGGCAUGGCAGGGUAUCGCC 25% ± 1% 31% ± 5% 
c13 GGCGAAGCCGUGUCAUGUCAUGAGUCCAUGGCAUGGCAUCUACACGCC 88% ± 3% 61% ± 8% 
c14 GGCGCCGGAAUGUCAUGUCAUGAGUCCAUGGCAUGGCAGUUGAGCGCC 49% ± 2% 71% ± 10% 
c15 GGCGACAUUGUGUCAUGUCAUGAGUCCAUGGCAUGGCAACGUUGCGCC 33% ± 1% 41% ± 12% 
c16 GGCGCCUGCAUGUCAUGUCAUGAGUCCAUGGCAUGGCAGGCCAUCGCC 40% ± 1% 44% ± 9% 
c17 GGCGGAUCCAUGUCAUGUCAUGAGUCCAUGGCAUGGCAAUGAAGCGCC 36% ± 1% 48% ± 6% 
c18 GGCGGUAGGGUGUCAUGUCAUGAGUCCAUGGCAUGGCAACGUAGCGCC 37% ± 1% 80% ± 12% 
c19 GGCGAGUAGGUGUCAUGUCAUGAGUCCAUGGCAUGGCACGCACACGCC 28% ± 1% 79% ± 8% 
c20 GGCGGUUUGAUGUCAUGUCAUGAGUCCAUGGCAUGGCAGCAGUUCGCC 29% ± 0% 73% ± 11% 
c21 GGCGUUUUAAUGUCAUGUCAUGAGUCCAUGGCAUGGCAAUUGUUCGCC 38% ± 1% 34% ± 5% 
c22 GGCGAUUAUGUGUCAUGUCAUGAGUCCAUGGCAUGGCAGUUAUGCGCC 49% ± 1% 42% ± 4% 
c23 GGCGAUGUGUUGUCAUGUCAUGAGUCCAUGGCAUGGCACAGACACGCC 88% ± 2% 60% ± 10% 
c24 GGCGAAUUUUUGUCAUGUCAUGAGUCCAUGGCAUGGCAGUAGGUCGCC 63% ± 2% 52% ± 8% 
c25 GGCGCUAUCAUGUCAUGUCAUGAGUCCAUGGCAUGGCACGUAAUCGCC 31% ± 1% 34% ± 5% 
c26 GGCGUACACAUGUCAUGUCAUGAGUCCAUGGCAUGGCAUUCUUGCGCC 77% ± 2% 55% ± 8% 
c27 GGCGACUUAUUGUCAUGUCAUGAGUCCAUGGCAUGGCAUCAAUACGCC 75% ± 2% 57% ± 8% 
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Supplementary Table SII. In vivo characterization data for the Rnt1p cleavage library in the context of ymCherry (pCS1749). All 
normalized protein and transcript levels are determined as described in Figure 1D. 
Substrate Normalized protein levels (%) Normalized transcript levels (%) 
C01 100% ± 5% 84% ± 10% 
C02 87% ± 4% 90% ± 5% 
C03 73% ± 5% 63% ± 5% 
C04 2% ± 0% 40% ± 6% 
C05 63% ± 5% 69% ± 9% 
C06 89% ± 5% 91% ± 6% 
C07 53% ± 2% 57% ± 9% 
C08 33% ± 2% 57% ± 8% 
C09 44% ± 2% 47% ± 5% 
C10 72% ± 2% 89% ± 2% 
C11 17% ± 1% 23% ± 3% 
C12 97% ± 6% 109% ± 5% 
C13 10% ± 1% 21% ± 2% 
C14 77% ± 4% 101% ± 4% 
A01 80% ± 7% 72% ± 5% 
A02 56% ± 3% 71% ± 7% 
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Supplementary Methods 
 
Rnt1p expression and purification. The pRNT1 plasmid was transformed into E. coli strain 
BL21 using the Z-competent E. coli Transformation Kit and Buffer Set (Zymo Research, 
Orange, CA) according to manufacturer’s instructions. Rnt1p was collected as a protein extract 
as previously described (Lamontagne & Elela, 2001). Briefly, an overnight culture of BL21 cells 
harboring pRNT1 was back-diluted to an OD600 of 0.5. Once the culture reached an OD600 of 1.1-
1.4, it was induced with 1 mM IPTG and grown for an additional 3 hr. The cells were 
centrifuged at 2,500g for 12 min at 4°C and the resulting cell pellet was frozen in a –80°C 
freezer. After weighing the frozen cell pellet, the cells were resuspended in 4 ml Ni2+ buffer 
[25% (v/v) glycerol, 1 M NaCl, 30 mM Tris pH 8.0] per gram of harvested cells. The 
resuspension was sonicated (Heat Systems-Ultrasonics, Inc.) twice with the following settings: 2 
x 30 sec, output control 5, and 50% duty cycle. Cellular debris was removed by centrifugation at 
20,000g for 30 min at 4°C and the supernatant was filtered through a 0.2-m pore size Acrodisc 
25 mm syringe filter (Pall Life Sciences, Ann Arbor, MI). 
Rnt1p was purified from the resulting supernatant with one 1-ml HisTrap HP column 
(GE Healthcare) on an AKTA FPLC machine (GE Healthcare). Elution of the protein was 
performed with an imidazole concentration of 150 mM in Ni2+ buffer and the protein was 
collected in 6 1-ml fractions. Protein purification was confirmed by analyzing an aliquot of each 
fraction on a SDS-PAGE gel (NuPAGE 4-12% Bis-Tris Gel, Invitrogen) and protein function 
was confirmed by incubating an aliquot of each fraction with a control Rnt1p substrate and 
analyzing the resulting cleavage products on an 8% denaturing polyacrylamide gel. Positive 
fractions were pooled and concentrated to less than a 3-ml volume using a Centricon Centrifugal 
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Filter Device (10,000 MWCO; Millipore) according to the manufacturer’s instructions. The 
concentrated protein was then injected into a Slide-A-Lyzer Dialysis Cassette (10,000 MWCO; 
Pierce Biotechnology) and buffer-exchanged twice with Rnt1p Storage Buffer [50% (v/v) 
glycerol, 0.5 M KCl, 30 mM Tris pH 8.0, 0.1 M DTT, 0.1 M EDTA] at 4ºC. The first buffer 
exchange took place for 4 hr and the second buffer exchange occurred overnight. The purified 
Rnt1p was stored in aliquots at -20°C. 
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